The CD-19 Antibody Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the CD-19 Antibody Market?
The CD-19 antibody market experienced noteworthy expansion in the past few years. The market size is predicted to increase from $1.75 billion in 2024 to $1.91 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the CD-19 Antibody Industry?
The CD-19 antibody market is projected to grow to a size of $2.70 billion in 2029, with a compound annual growth rate (CAGR) of 9.0%.
Download Your Free Sample of the 2025 CD-19 Antibody Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the CD-19 Antibody Market?
The key drivers in the cd-19 antibody market are:
• Growing demand for targeted cancer therapies
• Rising prevalence of hematologic malignancies
• Expansion of healthcare access in emerging markets
• Development of next-generation immunotherapies and improvement in biomanufacturing technologies
Global Market Segmentation: Identifying Major CD-19 Antibody Industry Segments
The CD-19 antibody market covered in this report is segmented –
1) By Disease Type: B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Other Disease Types
2) By Type: Polyclonal, Monoclonal
3) By Route Of Administration: Intravenous, Subcutaneous
4) By Application: Enzyme Linked Immunosorbent Assay, Flow Cytometry, Immunohistochemistry Frozen, Immunohistochemistry Paraffin, Other Applications
Subsegments:
1) By B-Cell Non-Hodgkin Lymphoma: Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Mantle Cell Lymphoma
2) By Chronic Lymphocytic Leukemia: Relapsed Or Refractory CLL, Treatment-Naïve CLL
3) By Acute Lymphoblastic Leukemia: B-Cell Precursor ALL, Philadelphia Chromosome-Positive ALL
4) By Other Disease Types: Hairy Cell Leukemia, Waldenström’s Macroglobulinemia, Marginal Zone Lymphoma
Pre-order the 2025 CD-19 Antibody Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the CD-19 Antibody Market?
The key trends in the cd-19 antibody market are:
• Advancements in antibody-drug conjugates are shaping the CD-19 antibody market.
• The development of bispecific antibodies is emerging as a significant trend.
• The integration of AI in antibody design is gaining traction.
• Automation in biologics manufacturing represents a critical emerging trend.
Who Are the Top Competitors & Leading Players in the CD-19 Antibody Market?
Major players in the cd-19 antibody market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• AstraZeneca plc
• Novartis AG
• Thermo Fisher Scientific Inc.
• Amgen Inc.
• Bio-Rad Laboratories Inc.
• Miltenyi Biotec GmbH
• Abcam Plc
• Kite Pharma Inc.
• BioLegend Inc.
• Xencor Inc.
• Juno Therapeutics Inc.
• BD Biosciences
• Zenas BioPharma Inc.
• Cell Signaling Technology Inc.
• Santa Cruz Biotechnology Inc.
• Novus Biologicals LLC
• Tonbo Biosciences Inc.
• Bio X Cell Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the CD-19 antibody market in 2024
